The global landscape of scientific publications in oncology reveals that smaller countries like Luxembourg, Malta, and Iceland have a high share of international collaboration, with Luxembourg leading at 78.67%. In contrast, larger research nations such as the United States, China, and Japan exhibit lower rates, indicating more self-contained research environments.
Over the last five years, international collaboration has likely remained steady or slightly grown in smaller and mid-sized countries due to increasing global research networks. Meanwhile, major countries, although still collaborating, may focus on independent research capacity.
Future trends to watch include:
- An increase in collaborations leveraging emerging technologies and data sharing platforms.
- Possible shifts in collaboration patterns due to geopolitical factors or funding changes.
- Growth in collaboration rates from countries with burgeoning biotech sectors like Vietnam and the UAE.
Top countries in Share of Scientific Publications Involving International Collaboration in Oncology by Country
| # | 10 Countries | Percent | Last Year | |
|---|---|---|---|---|
| 1 | 1 Luxembourg | 78.67 | 2023 | View data |
| 2 | 2 Malta | 74.36 | 2023 | View data |
| 3 | 3 Iceland | 70.22 | 2023 | View data |
| 4 | 4 United Arab Emirates | 61.68 | 2023 | View data |
| 5 | 5 Cyprus | 51.22 | 2023 | View data |
| 6 | 6 Switzerland | 50.92 | 2023 | View data |
| 7 | 7 Saudi Arabia | 49.11 | 2023 | View data |
| 8 | 8 Argentina | 48.19 | 2023 | View data |
| 9 | 9 Belgium | 48.14 | 2023 | View data |
| 10 | 10 Ireland | 46.6 | 2023 | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...